Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bavarian Nordic

Explore full profile

Biopharmaceutical company developing cancer immunotherapies and vaccines against infectious diseases

Gentofte Municipality, DenmarkFounded 1994Biotech & Life Sciences
Valuation $1.66B Market cap · Aug/2026
Revenue $815M Latest reported FY
EBITDA $225M Latest reported FY

At a glance

Founded
1994
Headquarters
Gentofte Municipality, Denmark
Listing
IPO 1998
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Bavarian Nordic.

See all news
Employees mapped 1,783 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 26 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
19 countries with
team presence
🇩🇰 Denmark59.8%
🇩🇪 Germany14.2%
🇨🇭 Switzerland13.4%
🇺🇸 United States8.3%
🇨🇦 Canada1.2%
Top 5 of 19 shown

Patents

Estimated portfolio value
$100M

64 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Bavarian Nordic on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bavarian Nordic on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.